ShawnGreenMD

PubMed

• Self-mapping the longitudinal field structure of a nonlinear plasma accelerator cavity.
  Clayton CE, Adli E, Allen J, An W, Clarke CI, Corde S, Frederico J, Gessner S, Green SZ, Hogan MJ, Joshi C, Litos M, Lu W, Marsh KA, Mori WB, Vafaei-Najafabadi N, Xu X...> ;Nat Commun. 2016-08-16
• Corrigendum: Mapping tree density at a global scale.
  Crowther TW, Glick HB, Covey KR, Bettigole C, Maynard DS, Thomas SM, Smith JR, Hintler G, Duguid MC, Amatulli G, Tuanmu M, Jetz W, Salas C, Stam C, Piotto D, Tavani R,...> ;Nature. 2016-04-14
• Multi-gigaelectronvolt acceleration of positrons in a self-loaded plasma wakefield.
  Corde S, Adli E, Allen JM, An W, Clarke CI, Clayton CE, Delahaye JP, Frederico J, Gessner S, Green SZ, Hogan MJ, Joshi C, Lipkowitz N, Litos M, Lu W, Marsh KA, Mori WB...> ;Nature. 2015-08-27
• High-efficiency acceleration of an electron beam in a plasma wakefield accelerator.
  Litos M, Adli E, An W, Clarke CI, Clayton CE, Corde S, Delahaye JP, England RJ, Fisher AS, Frederico J, Gessner S, Green SZ, Hogan MJ, Joshi C, Lu W, Marsh KA, Mori WB...> ;Nature. 2014-11-06
• Liposomal lipid A adjuvants and naturally occurring antibodies to cholesterol.
  Shawn J. Green> ;Vaccine. 2012 Mar 9
• Key discoveries often originate with lone researchers
  Shawn J. Green, Jon Brendsel> ;Nature. 2008 Nov 20
• 6 citations
  Regarding the potential perils of phytosterols.
  Jon Brendsel, Shawn J. Green> ;Atherosclerosis. 2007 May 1
• 2 citations
  Gut mucosa in HIV infection: "immune milk" solution.
  Shawn J Green> ;Plos Medicine. 2007 Feb 27
• Could the GI tract be a better portal for antibody therapy?
  Green SJ, Brendsel J> ;Gut. 2006-11-01
• 160 citations
  Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism
  Todd A. Hembrough, Glenn M. Swartz, Adonia E. Papathanassiu, George P. Vlasuk, William E. Rote, Shawn J. Green, Victor S. Pribluda> ;Cancer Research. 2003 Jun 1
• 126 citations
  2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway.
  Theresa LaVallee, Xiaoguo H. Zhan, Michelle S. Johnson, Chris J. Herbstritt, Glenn M. Swartz, Mark S. Williams, Wendy A. Hembrough, Shawn J. Green, Victor S. Pribluda> ;Cancer Research. 2003 Jan 15
• 166 citations
  2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
  Theresa LaVallee, Xiaoguo H. Zhan, Chris J. Herbstritt, Emily C. Kough, Shawn J. Green, Victor S. Pribluda> ;Cancer Research. 2002 Jul 1
• 79 citations
  Metastatin: A Hyaluronan-binding Complex from Cartilage That Inhibits Tumor Growth
  Ningfei Liu, Randall K. Lapcevich, Charles B. Underhill, Zeqiu Han, Feng Gao, Glenn M. Swartz, Stacy M. Plum, Lurong Zhang, Shawn J. Green> ;Cancer Research. 2001 Feb 2
• Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
  Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R> ;J. Infect.. 2000-03-01
• 209 citations
  2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.
  Victor S. Pribluda, Edward R. Gubish, Theresa LaVallee, Anthony M. Treston, Glenn M. Swartz, Shawn J. Green> ;Cancer Metastasis Reviews. 2000 Jan 1
• Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup...
  Taylor CW, Green S, Dalton WS, Martino S, Rector D, Ingle JN, Robert NJ, Budd GT, Paradelo JC, Natale RB, Bearden JD, Mailliard JA, Osborne CK> ;J. Clin. Oncol.. 1998-03-01
• Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast c...
  Albain KS, Green SR, Lichter AS, Hutchins LF, Wood WC, Henderson IC, Ingle JN, O'Sullivan J, Osborne CK, Martino S> ;J. Clin. Oncol.. 1996-11-01
• Maintaining low HIV seroprevalence in populations of injecting drug users.
  Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A> ;JAMA. 1995-10-18
• Mobility of Scottish injecting drug users and risk of HIV infection.
  Goldberg DJ, Frischer M, Taylor A, Green ST, McKeganey N, Bloor M, Reid D, Cossar J> ;Eur. J. Epidemiol.. 1994-08-01
• The value of acute medical services sited adjacent to areas of high drug-injecting activity.
  Green ST, Goldberg DJ, Carr SV, Taylor A, Frischer M, Gruer L> ;Addiction. 1994-06-01
• Prostitution: would legislation help?
  Carr SV, Goldberg DJ, Green ST> ;BMJ. 1994-02-19
• Comparison of four survey methods designed to estimate the prevalence of HIV among female prostitutes who inject drugs.
  Goldberg D, Green ST, Taylor A, Frischer M, McKeganey N> ;Int J STD AIDS. 1994-01-01
• Low and stable prevalence of HIV among drug injectors in Glasgow.
  Taylor A, Frischer M, Green ST, Goldberg D, McKeganey N, Gruer L> ;Int J STD AIDS. 1994-01-01
• Delineating peroxisome proliferator action to improve human risk assessment.
  Green S, Issemann I, Tugwood JD, Prince RA, Aldridge TC> ;Prog. Clin. Biol. Res.. 1994-01-01
• Do needle exchanges help to control the spread of HIV among injecting drug users?
  Frischer M, Elliott L, Taylor A, Goldberg D, Green S, Gruer L, Cameron J, McKeganey N, Bloor M> ;AIDS. 1993-12-01
• Join now to see all